Aclaris Therapeutics - 10 Year Stock Split History | ACRS

Stock split history for Aclaris Therapeutics since 2015. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Aclaris Therapeutics Annual Stock Splits
Aclaris Therapeutics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.139B $0.019B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $99.323B 37.26
Zoetis (ZTS) United States $70.523B 26.70
Daiichi Sankyo, - (DSNKY) Japan $49.922B 25.40
Takeda Pharmaceutical (TAK) Japan $48.938B 10.83
Summit Therapeutics (SMMT) United States $20.810B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.664B 0.00
Merck (MKKGY) Germany $18.359B 15.19
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $13.473B 11.92
Neurocrine Biosciences (NBIX) United States $10.858B 37.20
IPSEN (IPSEY) France $9.940B 0.00
Orion OYJ (ORINY) Finland $9.075B 24.54
Corcept Therapeutics (CORT) United States $7.841B 63.74
Madrigal Pharmaceuticals (MDGL) United States $6.803B 0.00
Stevanato Group S.p.A (STVN) Italy $6.702B 42.56
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.355B 0.00
Grifols, S.A (GRFS) Spain $5.122B 0.00
Soleno Therapeutics (SLNO) United States $3.817B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.151B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.964B 12.03
Hypermarcas (HYPMY) Brazil $2.350B 15.46
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.337B 12.78
BioCryst Pharmaceuticals (BCRX) United States $2.308B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.223B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.911B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.807B 0.00
Indivior (INDV) United States $1.641B 6.96
Guardian Pharmacy Services (GRDN) United States $1.610B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.400B 178.25
Dyne Therapeutics (DYN) United States $1.344B 0.00
Ocular Therapeutix (OCUL) United States $1.231B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.129B 45.89
Enliven Therapeutics (ELVN) United States $1.000B 0.00
Harrow (HROW) United States $0.907B 0.00
Ardelyx (ARDX) United States $0.894B 0.00
Collegium Pharmaceutical (COLL) United States $0.893B 4.74
Avadel Pharmaceuticals (AVDL) Ireland $0.874B 0.00
Xencor (XNCR) United States $0.763B 0.00
AleAnna (ANNA) United States $0.743B 0.00
Cronos Group (CRON) Canada $0.732B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Organogenesis (ORGO) United States $0.675B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Akebia Therapeutics (AKBA) United States $0.613B 0.00
Bioventus (BVS) United States $0.576B 14.96
Savara (SVRA) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
USANA Health Sciences (USNA) United States $0.546B 11.71
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.515B 0.00
CytoDyn (CYDY) United States $0.511B 0.00
Verve Therapeutics (VERV) United States $0.460B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.459B 0.00
Elite Pharmaceuticals (ELTP) United States $0.455B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Altimmune (ALT) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.409B 0.00
Siga Technologies (SIGA) United States $0.386B 6.59
Oruka Therapeutics (ORKA) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.341B 20.33
Heron Therapeutics (HRTX) United States $0.325B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Wellgistics Health (WGRX) United States $0.237B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.17
ProKidney (PROK) United States $0.220B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 26.25
OmniAb (OABI) United States $0.205B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.167B 0.00
Korro Bio (KRRO) United States $0.166B 0.00
4D Molecular Therapeutics (FDMT) United States $0.165B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.150B 46.38
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.126B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.116B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.68
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Karyopharm Therapeutics (KPTI) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.019B 7.60
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.14
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00